Back

NovoCure Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Sell

NVCR
NovoCure

Last Price:

12.10

Seasonality Move:

14.41%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

NovoCure Price Quote

$12.10

+0.05 (+0.41%)

(Updated: April 19, 2024 at 6:55 PM ET)

NovoCure Key Stats

Sell

NovoCure (NVCR) is a Sell

Day range:

$11.89 - $12.45

52-week range:

$10.87 - $83.60

Dividend yield:

P/E ratio:

0.00

P/S ratio:

2.52

P/B ratio:

3.56%

Volume:

1.2M

Avg. volume:

1.5M

1-year change:

-81.07%

Market cap:

$1.3B

Revenue:

$509.3M

EPS:

$-1.95

How Much Does NovoCure Make?

How Much Are NovoCure's Sales Annually?
NVCR Revenues are $509.3M
How Much Profit Does NovoCure's Make A Year?
NVCR net income is -$207M

Is NovoCure Growing As A Company?

What Is NovoCure's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04%
What Is NovoCure's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

NovoCure Stock Price Performance

Did NovoCure Stock Go Up Last Month?
NovoCure share price went down by -12.81% last month
Did NVCR's Share Price Rise Over The Last Year?
NVCR share price fell by -81.07% over the past 1 year

What Is NovoCure 52-Week High & Low?

What Is NovoCure’s 52-Week High Share Price?
NovoCure has traded as high as $83.60 over the past 52 weeks
What Is NovoCure’s 52-Week Low Share Price?
NovoCure has traded as low as $10.87 over the past 52 weeks

NovoCure Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NovoCure?

How Much Debt Does NovoCure Have?
Total long term debt quarterly is $568.8M
How Much Cash Does NovoCure Have?
Cash and short term investments quarterly total is $910.6M
What Is NovoCure’s Book Value Per Share?
Book value per share is 3.39

Is NovoCure Cash Flow Positive?

What Is NVCR Cash Flow From Operations?
Cash flow from operations (TTM) is -$73.3M
What Is NovoCure’s Cash Flow From Financing?
Cash flow from financing (TTM) is $15.8M
What Is NovoCure’s Cash Flow From Investing?
Cash flow from investing (TTM) is $184.1M

NovoCure Return On Invested Capital

Is Management Doing A Good Job?
NVCR return on invested capital is -21.21%
What Is NovoCure Return On Assets?
ROA measures how assets are converting to revenues and is -17.8%
What Is NVCR Return On Equity?
ROE is a measure of profitability and is -50.62%

NovoCure Earnings Date & Stock Price

What Is NovoCure's Stock Price Today?
A single share of NVCR can be purchased today for 12.05
What Is NovoCure’s Stock Symbol?
NovoCure trades on the nasdaq under the ticker symbol: NVCR
When Is NovoCure’s Next Earnings Date?
The next quarterly earnings date for NovoCure is scheduled on May 2, 2024
When Is NVCR's next ex-dividend date?
NovoCure's next ex-dividend date is April 20, 2024
How To Buy NovoCure Stock?
You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

NovoCure Competitors

Who Are NovoCure's Competitors?
Below is a list of companies who compete with NovoCure or are related in some way:
- AtriCure Inc (ATRC)
- Perspective Therapeutics Inc (CATX)
- NeuroMetrix Inc (NURO)
- Repligen Corp (RGEN)
- Teleflex Inc (TFX)

NovoCure Dividend Yield